Brittany Taylor
Family Medicine · Huntsville, ALNPI 1740956127
Payments from drug & device makers
Across 178 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$975
- Novo Nordisk$410
- AbbVie$246
- Corium, LLC$185
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$135
- Pfizer$127
- plus $855 from 18 others
What the payments were for
- Food & beverage$2,88898%
- Education$452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 66 | $975 |
| Novo Nordisk | 24 | $410 |
| AbbVie | 15 | $246 |
| Corium, LLC | 9 | $185 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $135 |
| Pfizer | 7 | $127 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $121 |
| Exact Sciences | 6 | $103 |
| Bayer | 5 | $101 |
| Tolmar, Inc. | 5 | $82 |
| Boehringer Ingelheim | 5 | $79 |
| GSK | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $46 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Bausch Health US, LLC | 2 | $30 |
| Genentech USA, Inc. | 2 | $29 |
| Johnson & Johnson | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $16 |
| AstraZeneca | 1 | $15 |
How this compares
$2,933 in reported general payments places this provider in the 75th percentile of 1,680 family medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 76 | $1,284 |
| Rosuvastatin Calcium | 79 | $916 |
| Omeprazole | 49 | $448 |
| Valsartan | 11 | $445 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 18 | $445 |
| Metoprolol Succinate | 30 | $415 |
| Cyclobenzaprine Hcl | 12 | $403 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $401 |
| Losartan Potassium | 33 | $343 |
| Trazodone Hcl | 22 | $334 |
| Famotidine | 18 | $278 |
| Tamsulosin Hcl | 15 | $236 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $213 |
| Levothyroxine Sodium | 31 | $210 |
| Metformin Hcl | 16 | $209 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Huntsville
- Michael CarterHuntsville$3.4M
- Randle MiddletonHuntsville$3.3M
- Timothy HowardHuntsville$3M
- Edward WittHuntsville$321K
- Kathleen DupperHuntsville$210K
- Whitney TewHuntsville$114K
- Jeffrey GarberHuntsville$87K
- Daniel EnglertHuntsville$82K
- Jack EnglertHuntsville$37K
- Tobin FisherHuntsville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.